Blocking a Key Protein Gives Boost to Immune System Monday, April 15, 2013 UCLA scientists have shown that temporarily blocking a protein critical to immune response actually helps the body clear itself of chronic infection. MRC Technology and EMBLEM Collaborate to Streamline Drug Development Monday, April 15, 2013 Initiative strengthens drug development and commercialization network. Atox Bio Publishes Data Demonstrating the Broad Therapeutic Effect of AB103 Monday, April 15, 2013 Findings published in the Journal of Infectious Diseases. Ares Life Sciences to Acquire Antigen Laboratories, Inc., in the United States Monday, April 15, 2013 Ares Life Sciences announced that it has signed a definitive agreement to acquire 100% of the share capital of Planet Biopharmaceuticals, Inc. Immune Response Linked to Key Enzyme Friday, April 12, 2013 A family of enzymes may contribute to scientists’ understanding of signaling molecules involved in the body’s immune response. Early Results of Activartis AV0113 Cancer Immunotherapy in Glioblastoma Trial Reveal Promising Trend Thursday, April 11, 2013 Glioblastoma multiforme (GBM) is the most severe form of brain cancer and progresses rapidly. Catalent Biologics Expands into ADCs through Exclusive License with Redwood Bioscience Thursday, April 11, 2013 SMARTag™ Advanced conjugation technology to be presented at BIO International. Data Examines Induction of Systemic Immune Response in Multiple Tumor Types Thursday, April 11, 2013 Provectus Pharmaceuticals, Inc. announced details of a poster presentation on the induction of a systemic immune response with intralesional (IL) PV-10. Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant Thursday, April 11, 2013 Inovio to advance painless device to simultaneously deliver multiple vaccines using electroporation technology.
|
|
|
|
|
|